
### [MONDO:0017675](http://purl.obolibrary.org/obo/MONDO_0017675)
**Label:** punctate palmoplantar keratoderma

**Subclasses:** [MONDO:0013980](http://purl.obolibrary.org/obo/MONDO_0013980) (PPKP1B), [MONDO:0014574](http://purl.obolibrary.org/obo/MONDO_0014574) (peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome), [MONDO:0008292](http://purl.obolibrary.org/obo/MONDO_0008292) (punctate palmoplantar keratoderma type 2), [MONDO:0017677](http://purl.obolibrary.org/obo/MONDO_0017677) (focal acral hyperkeratosis), [MONDO:0017676](http://purl.obolibrary.org/obo/MONDO_0017676) (marginal papular palmoplantar keratoderma), [MONDO:0017679](http://purl.obolibrary.org/obo/MONDO_0017679) (autosomal dominant disease associated with punctate palmoplantar keratoderma as a major feature), [MONDO:0016545](http://purl.obolibrary.org/obo/MONDO_0016545) (leukoencephalopathy-palmoplantar keratoderma syndrome), [MONDO:0017678](http://purl.obolibrary.org/obo/MONDO_0017678) (disease with punctate palmoplantar keratoderma as a major feature), [MONDO:0016353](http://purl.obolibrary.org/obo/MONDO_0016353) (palmoplantar keratoderma-spastic paralysis syndrome), [MONDO:0017680](http://purl.obolibrary.org/obo/MONDO_0017680) (autosomal recessive disease associated with punctate palmoplantar keratoderma as a major feature), [MONDO:0019332](http://purl.obolibrary.org/obo/MONDO_0019332) (punctate palmoplantar keratoderma type 1), [MONDO:0007858](http://purl.obolibrary.org/obo/MONDO_0007858) (palmoplantar keratoderma, punctate type 1A), [MONDO:0007757](http://purl.obolibrary.org/obo/MONDO_0007757) (hyperkeratosis-hyperpigmentation syndrome), [MONDO:0007047](http://purl.obolibrary.org/obo/MONDO_0007047) (punctate palmoplantar keratoderma type III), [MONDO:0016518](http://purl.obolibrary.org/obo/MONDO_0016518) (isolated punctate palmoplantar keratoderma), [MONDO:0014227](http://purl.obolibrary.org/obo/MONDO_0014227) (hypopigmentation-punctate palmoplantar keratoderma syndrome), [MONDO:0008291](http://purl.obolibrary.org/obo/MONDO_0008291) (porokeratosis plantaris palmaris et disseminata), 

**Mapped go classes:** [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0047429](http://purl.obolibrary.org/obo/GO_0047429) (nucleoside-triphosphate diphosphatase activity), [GO:0097441](http://purl.obolibrary.org/obo/GO_0097441) (basal dendrite), [GO:0097440](http://purl.obolibrary.org/obo/GO_0097440) (apical dendrite), [GO:0030505](http://purl.obolibrary.org/obo/GO_0030505) (inorganic diphosphate transport), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0045296](http://purl.obolibrary.org/obo/GO_0045296) (cadherin binding), [GO:0010859](http://purl.obolibrary.org/obo/GO_0010859) (calcium-dependent cysteine-type endopeptidase inhibitor activity), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:2000675](http://purl.obolibrary.org/obo/GO_2000675) (negative regulation of type B pancreatic cell apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0031953](http://purl.obolibrary.org/obo/GO_0031953) (negative regulation of protein autophosphorylation), [GO:0030500](http://purl.obolibrary.org/obo/GO_0030500) (regulation of bone mineralization), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0090305](http://purl.obolibrary.org/obo/GO_0090305) (nucleic acid phosphodiester bond hydrolysis), [GO:0006091](http://purl.obolibrary.org/obo/GO_0006091) (generation of precursor metabolites and energy), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0055062](http://purl.obolibrary.org/obo/GO_0055062) (phosphate ion homeostasis), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0005044](http://purl.obolibrary.org/obo/GO_0005044) (scavenger receptor activity), [GO:0004551](http://purl.obolibrary.org/obo/GO_0004551) (nucleotide diphosphatase activity), [GO:0007343](http://purl.obolibrary.org/obo/GO_0007343) (egg activation), [GO:0046627](http://purl.obolibrary.org/obo/GO_0046627) (negative regulation of insulin receptor signaling pathway), [GO:0097340](http://purl.obolibrary.org/obo/GO_0097340) (inhibition of cysteine-type endopeptidase activity), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity), [GO:0043086](http://purl.obolibrary.org/obo/GO_0043086) (negative regulation of catalytic activity), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0046034](http://purl.obolibrary.org/obo/GO_0046034) (ATP metabolic process), [GO:0030730](http://purl.obolibrary.org/obo/GO_0030730) (sequestering of triglyceride), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0071157](http://purl.obolibrary.org/obo/GO_0071157) (negative regulation of cell cycle arrest), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0016036](http://purl.obolibrary.org/obo/GO_0016036) (cellular response to phosphate starvation), [GO:0030247](http://purl.obolibrary.org/obo/GO_0030247) (polysaccharide binding), [GO:0030643](http://purl.obolibrary.org/obo/GO_0030643) (cellular phosphate ion homeostasis), [GO:0031214](http://purl.obolibrary.org/obo/GO_0031214) (biomineral tissue development), [GO:0009141](http://purl.obolibrary.org/obo/GO_0009141) (nucleoside triphosphate metabolic process), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0046849](http://purl.obolibrary.org/obo/GO_0046849) (bone remodeling), [GO:0030163](http://purl.obolibrary.org/obo/GO_0030163) (protein catabolic process), [GO:0045719](http://purl.obolibrary.org/obo/GO_0045719) (negative regulation of glycogen biosynthetic process), [GO:0009143](http://purl.obolibrary.org/obo/GO_0009143) (nucleoside triphosphate catabolic process), [GO:0045599](http://purl.obolibrary.org/obo/GO_0045599) (negative regulation of fat cell differentiation), [GO:0046325](http://purl.obolibrary.org/obo/GO_0046325) (negative regulation of glucose import), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0006796](http://purl.obolibrary.org/obo/GO_0006796) (phosphate-containing compound metabolic process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0035529](http://purl.obolibrary.org/obo/GO_0035529) (NADH pyrophosphatase activity), [GO:0004528](http://purl.obolibrary.org/obo/GO_0004528) (phosphodiesterase I activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0004527](http://purl.obolibrary.org/obo/GO_0004527) (exonuclease activity), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0050427](http://purl.obolibrary.org/obo/GO_0050427) (3'-phosphoadenosine 5'-phosphosulfate metabolic process), [GO:0017111](http://purl.obolibrary.org/obo/GO_0017111) (nucleoside-triphosphatase activity), [GO:0030279](http://purl.obolibrary.org/obo/GO_0030279) (negative regulation of ossification), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [GO:0010859](http://purl.obolibrary.org/obo/GO_0010859) (calcium-dependent cysteine-type endopeptidase inhibitor activity) 52.27%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000745](http://purl.obolibrary.org/obo/GO_2000745) (obsolete positive regulation of transcription from RNA polymerase III promoter involved in smooth muscle cell differentiation)) 37.63%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000695](http://purl.obolibrary.org/obo/GO_2000695) (null)) 37.63%


